Clinical Trials
9 trialsNCT04907539 2025-04-16
A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberrated, Metastatic, Microsatellite Stable, Colorectal Cancer After Progression on Standard of Care (SOC)
Redx Pharma Ltd
Phase 2 Completed
NCT04907851 2025-03-17
KEYNOTE-E86
Redx Pharma Ltd
Phase 2 Completed
NCT00396279 2022-11-08
Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone
Amgen
Phase 2 Completed
NCT00680992 2022-09-22
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Amgen
Phase 2 Completed
NCT01951586 2021-10-25
Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer
Amgen
Phase 2 Completed
NCT00896454 2018-10-17
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Amgen
Phase 2 Completed
NCT00259740 2017-03-15
Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - Denosumab
Amgen
Phase 2 Completed
NCT00091832 2014-01-28
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Amgen
Phase 2 Completed
NCT00104650 2011-01-24
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
Amgen
Phase 2 Completed